Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's GHG Emissions Data Preview

In 2023, Innovent Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Innovent Biologics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Innovent Biologics’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Innovent Biologics’s data sources below and access millions more through our Disclosure Search.

a. Innovent Biologics's ESG Report 2023
a. Innovent Biologics's ESG Report 2023
b. Innovent Biologics's ESG Report 2022
b. Innovent Biologics's ESG Report 2022

Insights into Innovent Biologics's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Innovent Biologics amounted to 15,894.42 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Innovent Biologics decreased by 28.73%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b

Innovent Biologics's Scope 1 Emissions Over Time

20222023020406080tCO2e-2%
  • Total Scope 1
  • Year-over-Year Change

What are Innovent Biologics's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Innovent Biologics were 65.17 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2022), Innovent Biologics's Scope 1 emissions decreased by 2.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b

What are Innovent Biologics's Scope 2 emissions?

In 2023, Innovent Biologics reported Scope 2 greenhouse gas (GHG) emissions of 15,829.25 tCO₂e without specifying the calculation method. a

Has Innovent Biologics reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Innovent Biologics's Scope 2 emissions (Unspecified Calculation Method) fell by 28.81% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a b

What methodology does Innovent Biologics use for Scope 2 reporting?

In 2023, Innovent Biologics reported its Scope 2 emissions using an unspecified methodology. a

Innovent Biologics's Scope 2 Emissions Over Time

2022202306 k12 k18 k24 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Innovent Biologics’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Innovent Biologics reported Scope 1 greenhouse gas (GHG) emissions of 65.17 tCO₂e and total revenues of USD 953 millions. This translates into an emissions intensity of 0.07 tCO₂e per millions USD. a

Innovent Biologics's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202002,00020,000Revenues (Millions of USD)AASAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2023Scope 1: 0 tCO2eRevenue: $M 19Scope 1 Intensity: 0.02 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$MZhifeiYear: 2023Scope 1: 14,211 tCO2eRevenue: $M 7,446Scope 1 Intensity: 1.91 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2023Scope 1: 46,854 tCO2eRevenue: $M 1,101Scope 1 Intensity: 42.55 tCO2e/$MWuXi Biologics (Cayman)Year: 2023Scope 1: 32,687 tCO2eRevenue: $M 2,603Scope 1 Intensity: 12.56 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MGenor Biopharma HoldingsYear: 2022Scope 1: 18 tCO2eRevenue: $M 3Scope 1 Intensity: 7.17 tCO2e/$MInnovent BiologicsYear: 2023Scope 1: 65 tCO2eRevenue: $M 953Scope 1 Intensity: 0.07 tCO2e/$M

How does Innovent Biologics's GHG emissions intensity compare to its peers?

In 2023, Innovent Biologics reported a Scope 1 emissions intensity of 0.07 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Innovent Biologics rank on GHG emissions intensity within its industry?

In 2023, Innovent Biologics ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Innovent Biologics among the top performers, with one of the lowest emissions intensities relative to peers. a

Want Full Access to Innovent Biologics's GHG Emissions Dataset?
Sign Up